At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
GP0045 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Controlled, Evaluator-blinded, Split Face Study to Evaluate the Performance and Safety of GP0045 for Correction of Moderate to Severe Nasolabial Folds
In Brief
A clinical study evaluating GP0045 and Comparator for Nasolabial Fold and Safety. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This is a study to assess the performance and safety of GP0045 when injected in the nasolabial folds. There is an 18 months follow up period.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNasolabial Fold, Safety
CountriesSweden
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartOct 2017
First PostedOct 2017
Primary CompletionApr 2018
Study CompletionApr 2019
TodayJul 2026
First PostedOct 3, 2017
Enrollment StartOct 2, 2017
Primary CompletionApr 27, 2018
Study CompletionApr 24, 2019
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 8.7 years ago
Interventions
GP0045device
Hyaluronic acid gel
Comparatordevice
Hyaluronic acid gel